Insider: McCarthy Sean A. CEO - CytomX Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,089,684 | 93,118 | 1,182,802 |
| Value | $3,160,083.60 | $270,042.20 | $3,430,125.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 06/16/2025 | DDS | 55,511 | Direct | COM | $2.69 | $149,263.53 | 1,089,684 |
| 03/18/2025 | DDS | 37,656 | Direct | COM | $0.60 | $22,555.94 | 995,195 |
| 08/20/2024 | DDS | 13,898 | Direct | COM | $1.23 | $17,082.03 | 657,851 |
| 03/19/2024 | DDS | 20,223 | Direct | COM | $2.09 | $42,175.07 | 524,481 |
| 12/20/2023 | DDS | 13,551 | Direct | COM | $1.38 | $18,709.87 | 454,704 |
| 09/22/2023 | DDS | 14,601 | Direct | COM | $1.30 | $18,987.14 | 430,755 |
| 03/16/2023 | DDS | 7,121 | Direct | COM | $1.88 | $13,391.04 | 388,821 |
| 07/20/2022 | DDS | 14,911 | Direct | COM | $1.42 | $21,206.42 | 290,942 |
| 06/16/2021 | DDS | 100,000 | Indirect | COM | $7.04 | $704,470.00 | 93,118 |
| 05/12/2020 | DDS | 36,000 | Direct | COM | $15.00 | $540,000.00 | 84,306 |
| 11/02/2018 | DDS | 1,156 | Direct | COM | $15.01 | $17,348.09 | 82,063 |
| 11/01/2018 | DDS | 100 | Direct | COM | $15.01 | $1,500.50 | 87,333 |
| 11/01/2018 | DDS | 5,270 | Direct | COM | $15.00 | $79,050.00 | 82,063 |
| 07/05/2018 | DDS | 4,497 | Direct | COM | $25.06 | $112,688.52 | 82,063 |
| 07/03/2018 | DDS | 2,028 | Direct | COM | $25.09 | $50,880.49 | 82,063 |
| 07/02/2018 | DDS | 13,052 | Direct | COM | $23.42 | $305,707.86 | 82,063 |
| 05/01/2018 | DDS | 19,578 | Direct | COM | $26.55 | $519,743.04 | 4,643 |
| 03/01/2018 | DDS | 19,578 | Direct | COM | $29.43 | $576,141.38 | 4,643 |
| 01/05/2018 | DDS | 6,526 | Direct | COM | $25.01 | $163,215.26 | 4,643 |
| 01/02/2018 | DDS | 13,052 | Direct | COM | $21.04 | $274,614.08 | 4,643 |
| 12/01/2017 | DDS | 14,340 | Direct | COM | $20.60 | $295,404.00 | 4,643 |
| 11/01/2017 | DDS | 14,342 | Direct | COM | $19.86 | $284,832.12 | 4,245 |
| 10/04/2017 | DDS | 19,120 | Direct | COM | $24.13 | $461,365.60 | 4,245 |
| 10/02/2017 | DDS | 9,562 | Direct | COM | $18.57 | $177,566.34 | 4,245 |
| 09/01/2017 | DDS | 9,930 | Direct | COM | $17.32 | $171,987.60 | 4,245 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research